It is impractical to perform polysomnography (PSG) in all surgical patients suspected of having sleep disordered breathing (SDB). We investigated the role of nocturnal oximetry in diagnosing SDB in surgical patients. METHOD: All patients 18 years and older who visited the preoperative clinics for scheduled inpatient surgery were approached for study participation. Patients expected to have abnormal electroencephalographic findings were excluded. All patients underwent an overnight PSG at home with a portable device and a pulse oximeter. The PSG recordings were scored by a certified sleep technologist. The oximetry recordings were processed electronically. RESULT: Four hundred seventy-five patients completed the study: 217 males and 258 females, aged 60 Ϯ 11 years, and body mass index 31 Ϯ 7 kg/m 2 . The apnea-hypopnea index (AHI), the average number of episodes of apnea and hypopnea per hour of sleep, was 9.1 (2.8 to 21.4) [median (interquartile range)] and 64% patients had AHI Ͼ5. There was a significant correlation between oxygen desaturation index (ODI, hourly average number of desaturation episodes) and cumulative time percentage with SpO 2 Ͻ90% (CT90) from nocturnal oximetry, with the parameters measuring sleep breathing disorders from PSG. Compared to CT90, ODI had a stronger correlation and was a better predictor for AHI. The area under receiver operator characteristics curve for ODI to predict AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30 was 0.908 (CI: 0.880 to 0.936), 0.931 (CI: 0.090 to 0.952), and 0.958 (CI: 0.937 to 0.979), respectively. The cutoff value based on the maximal accuracy for ODI to predict AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30 was ODI Ͼ5, ODI Ͼ15, and ODI Ͼ30. The accuracy was 86% (CI: 83%-88%), 86% (CI: 83%-89%), and 94% (CI: 92%-96%), respectively. The ODI Ͼ10 demonstrated a sensitivity of 93% and a specificity of 75% to detect moderate and severe SDB. CONCLUSIONS: ODI from a high-resolution nocturnal oximeter is a sensitive and specific tool to detect undiagnosed SDB in surgical patients.
O bstructive sleep apnea (OSA) is one of the most frequent constituents of sleep disordered breathing (SDB). Growing evidence has implicated OSA as a causal pathway to the development of cardiorespiratory diseases, diabetes mellitus and autoimmune diseases. [1] [2] [3] The all-cause mortality is increased in proportion with the severity of SDB. 4 OSA can pose a significant challenge to anesthesiologists in the perioperative period due to the patient's possible difficult airway, increased sensitivity to narcotics, and postoperative upper airway obstruction. 5 It has been shown that OSA patients have an increased incidence of perioperative adverse events. 6 -8 In the general population, OSA was found in 24% of men and 9% of women with apnea-hypopnea index (AHI) Ն5 and in 11.4% of men and 4.7% of women with AHI Ն15 as the OSA diagnostic criteria. 9 It is estimated that nearly 80% of men and 93% of women with moderate to severe sleep apnea are undiagnosed. 10 Identifying the surgical patient with undiagnosed OSA allows the clinician to develop the appropriate perioperative management plan. In-laboratory polysomnography (PSG) is the gold standard for diagnosing OSA. 11 However, in-laboratory PSG is a time-consuming and costly procedure. Referring patients to sleep clinics usually results in postponing surgery. Most portable sleep monitoring devices also require intensive training of patients or assistance from well-trained technicians, and manual scoring of recordings by certified PSG technologists. Lack of convenient and economical diagnostic tools is a major obstacle that prevents anesthesiologists from diagnosing OSA and initiating treatment before surgery.
A high resolution oximeter is a watch oximeter with high sampling frequency and resolution, which requires little training to install properly. It can detect the fluctuations in oxygen saturation caused by episodes of apnea and hypopnea. In addition, the data can be automatically analyzed with commercially available computer programs with an acceptable accuracy. Although oximetry has been studied as a screening tool in sleep clinic patients, 12, 13 no study has been published to evaluate the diagnostic performance of oximetry for SDB in the surgical patient. The objective of this study was to evaluate the predictive performance of a high-resolution oximeter in detecting SDB in surgical patients. Our hypothesis was that nocturnal oximetry is a simple alternative to PSG in diagnosing SDB in the preoperative clinic.
METHODS

Study Subjects
The study was performed at Toronto Western Hospital of University Health Network and Mount Sinai Hospital in Toronto. Approvals from the IRB of both hospitals were obtained. Written informed consent was obtained from all study subjects. Patients 18 years and older were potential candidates for the study. Patients who were unwilling or unable to give informed consent or patients who were expected to have abnormal electroencephalographic (EEG) findings (e.g., brain tumor, epilepsy surgery, patients with deep brain stimulator) were excluded. All eligible patients who visited the preoperative clinics for a scheduled inpatient surgery were approached. The patients giving study consent underwent an entire night of portable PSG and simultaneous oximetry preoperatively at the patients' homes.
In patients with an AHI Ͼ5, their family physicians were notified so that the patients could be referred to sleep physicians for further clinical management.
Oximeter
Simultaneously, SaO 2 monitoring with a high-resolution pulse oximeter wristwatch (PULSOX-300i, Konica Minolta Sensing, Inc., Osaka, Japan) was performed along with portable PSG (Embletta ϫ100, Embla, Broomfield, CO). Each oxygen probe of the oximeter and PSG were attached to different fingers of the nondominant hand. The sampling frequency of the oximeter PULSOX-300i is 1 Hz on memory interval and an averaging time of 3 seconds. The resolution is 0.1% Spo 2 (information provided by the manufacturer). The data were downloaded into a personal computer the following morning and were processed with a specifically designed computer program, Profox (Profox Associates, Escondido, CA). First, the oximetry recording was visually checked by the technician and obvious artifacts were deleted. The aberrant recording was then scanned and excluded. Next, oxygen desaturation index (ODI), cumulative time percentage with Spo 2 Ͻ90% (CT90), lowest and average Spo 2 were extracted from the oximetry data. ODI is the hourly average number of desaturation episodes, which are defined as at least 4% decrease in saturation from the average saturation in the preceding 120 seconds, and lasting Ͼ10 seconds.
To minimize the bias from oximetry data recorded while the patient was awake, only oximetry recordings obtained between 00:00 hours and 6:00 hours were processed, although it was not known if patients were actually asleep during this entire period. Data processing was performed by a technician blinded to PSG results.
Ambulatory Polysomnography
A full-night unattended portable PSG recording with Embletta ϫ 100 was performed at the patient's home preoperatively. Embletta ϫ100 is a level 2 diagnostic tool for OSA 14 and has been validated against laboratory PSG.
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The PSG recording montage consisted of 2 EEG channels (C3 and C4), left or right electroculogram, chin muscle electromyogram, nasal cannula (pressure), thoracic and abdominal respiratory effort bands, body-position sensor, and pulse oximetry. The device measures the oxyhemoglobin saturation at a rate of 3 samples per second. The averaging time is one-third of a second. At bedtime, the device was connected to the patients by a trained PSG technician at the patients' homes. The overnight recording was unattended. The patients were taught how to disconnect the device, which was retrieved by the same sleep technician the following morning. Patients were asked to keep a sleep diary. The sleep technician retrieving the device ensured that the sleep diary was completed by the patient.
Recordings from the portable PSG were scored by a certified PSG technologist and reviewed by a physician specialized in sleep medicine. Both were blinded to the clinical information and the results of the oximetry. Somnologia Studio 5.0 (Embla, Broomfield, CO) was the platform used for scoring PSG. The PSG recording was manually scored epoch by epoch by the PSG technologist, according to the manual published by the American Academy of Sleep Medicine in 2007. 16 Apnea was defined as a Ͼ90% decrease in air flow from baseline, which lasted at least 10 seconds. Apneas were classified as obstructive apnea if respiratory effort was present, central apnea if respiratory effort was absent during the event, or mixed apnea if characteristics of both obstructive or central apnea are present. Hypopnea was defined as a Ն30% reduction in air flow which lasted at least 10 seconds and was associated with a decrease of at least 4% in arterial oxyhemoglobin saturation. The AHI was defined as the number of episodes of apnea and hypopnea per hour of sleep.
Data Analysis and Statistics
Sample Size Estimation
The calculation of sample size was performed according to the method reported by Obuchowski. 17 The sample size was calculated based on the sensitivity and specificity of ODI Ն10 for the prediction of AHI Ն5 from a previous study of patients suspected of having OSA 18 and prevalence of OSA. 19, 20 When a sensitivity of 0.82, a precision of 0.09, an OSA prevalence rate of 24%, a type I error of 0.05, and a power of 0.8 were used for sample size estimation, the power analysis resulted in 368 patients. Based on the specificity of 0.76 and a precision of 0.09, the sample size was 107 patients. To ensure sufficient power for estimation of sensitivity, a sample size of Ͼ368 patients was required.
Data Analysis
Data were entered into a specifically designed Microsoft Access database (Microsoft Corp., Redmond, WA) and checked for possible errors. SAS 9.1 for Windows (SAS Institute, Cary, NC) was used for data analysis. All the statistical tests were 2-tailed and P Ͻ 0.05 was accepted as statistically significant.
The demographic data, summary of data from the PSG, and nocturnal oximeter were presented with descriptive statistics. Categorical data were presented as frequency with percentage, and the statistical significance was checked by 2 ODI and CT90 measured with nocturnal oximetry were compared with AHI simultaneously measured with portable home PSG. The Spearman correlation between variables from PSG with ODI and CT90 from high-resolution oximetry was analyzed. The receiver operator characteristics (ROC) curve and the area under ROC (AUC) for ODI and CT90 to predict OSA at different AHI cutoffs were analyzed with output data from logistic regression. Scatter plot and simple linear regression between ODI and AHI were depicted and explored. Bland-Altman analysis for AHI and ODI, the agreement between AHI and ODI, was also presented. Optimal cutoffs for ODI and CT90 were chosen according to maximal total accuracy (total accuracy ϭ [true positive ϩ true negative]/N). A validation dataset of 475 observations was generated from the original dataset by resampling with bootstrapping. The sensitivity, specificity, positive predictive value, negative predictive value, positive and negative likelihood ratio, and accuracy with 95% confidence intervals of ODI and CT90 at chosen cutoffs were also examined on the validation dataset to evaluate the predictive performance of ODI for SDB at different cutoffs of AHI.
RESULTS
In 2 years (December 2007 to November 2009), 3760 patients seen in the preoperative clinic were invited to participate in this study, and 503 consented and 475 completed the study satisfactorily. Seventeen patients withdrew from the study because of a change of mind (10), preoperative stress (2), misunderstanding (3), incorrect contact information (1), and participating in another research study (1) . Four hundred eighty-six surgical patients underwent portable PSG preoperatively at home. Of them, the PSG quality of 11 patients was technically unreliable. Four hundred seventy-five patients who had recordings of good quality on both PSG and oximetry were included in this report.
Compared to 3285 patients who were approached but not included in this report, the 475 patients included in the final analysis were older (60.3 Ϯ 12.7 year vs 58.5 Ϯ 14.5 year, P ϭ 0.003), had a larger body mass index (30.5 Ϯ 6.8 vs 28.6 Ϯ 6.1, P Ͻ 0.001) and neck circumference (38.7 Ϯ 4.2 vs 37.7 Ϯ 5.0, P Ͻ 0.001). The demographic data, type of surgery, and preexisting medical conditions of 475 patients are summarized in Table 1 . The most common type of surgery was orthopedic (56%).
The AHI was 9.1 (2.8 to 21.4) [median (IQR)]. There were 171 (36%) patients who had an AHI Յ5, 138 (29%) patients who had an AHI Ͼ5 and Յ15, 92 (19%) patients who had an AHI Ͼ15 and Յ30, and 74 (16%) patients who had an AHI Ͼ30. Sleep study data are summarized in Table 2 . Compared with the patients with ODI Յ5, there was a significant frequency of episodes of sleep breathing disorders in patients with ODI Ͼ5. Although patients with ODI Ͼ5 had more central apnea episodes compared with patients with ODI Յ5, the frequency of central apnea in the study population was very low, 0 (0 -0) [median (IQR)] or 0.18 Ϯ 0.94 (mean Ϯ SD).
The ODI was 9.8 (4.6 to 17.3) [median (IQR)]. There were 128 (27%) patients who had an ODI Յ5, 203 (43%) patients who had an ODI Ͼ5 and Յ15, 77 (16%) patients who had an ODI Ͼ15 and Յ30, and 64 (14%) patients who had an ODI Ͼ30. Oximeter data are shown in Table 3 . Compared with patients with AHI Յ5, the patients with AHI Ͼ5 had a higher ODI and CT90, a lower average Spo 2 , and lowest Spo 2 . The correlation between the major parameters of SDB as obtained from the portable PSG and ODI or CT90 from the oximeter is shown in Table 4 . There was a strong correlation (r s : 0.70 to 0.90) between the ODI and AHI, hypopnea index, nonrapid eye movement AHI, rapid eye movement AHI, respiratory arousal index, and the lowest Spo 2 on PSG. There was a moderate correlation (r s : 0.40 to 0.69) between the ODI and obstructive apnea index. There was a weak correlation (r s : 0.20 to 0.39) between the ODI and mixed apnea index. There was a very weak correlation (r s Յ0. 19 ) between the ODI and central apnea index. A correlation between CT90 from the oximeter and the above parameters from PSG was also found (Table 4 ). However, the Spearman coefficients (r s ) were much smaller. There was no overlapping in 95% confidence intervals of r s for ODI with AHI , hypopnea index, nonrapid eye movement AHI, rapid eye movement AHI and respiratory arousal index, and CT90 with the above parameters.
The relationship between the ODI and AHI is further depicted in Figure 1 and Figure 2 To compare the accuracy of the ODI and CT90 to predict SDB at different AHI cutoffs, the ROC curves and the area There was a strong correlation between ODI and AHI, hypopnea Index, AHI-REM, AHI-NREM, and respiratory arousal index (r s Ͼ0.7); 78.5% variance of AHI could be explained by ODI. AHI ϭ apnea-hypopnea index; AHI-NREM ϭ AHI during nonrapid eye movement sleep; AHI-REM ϭ AHI during rapid eye movement sleep; CT90 ϭ cumulative time percentage with SpO 2 Ͻ90%; ODI ϭ oxygen desaturation index; r s ϭ Spearman correlation coefficient; PSG ϭ polysomnography.
under ROC curves for ODI and CT90 at AHI cutoffs of 5, 15, and 30 are presented in Figure 3 and Figure 4 . The accuracy of ODI to predict SDB at different cutoffs was significantly higher than CT90. ODI was a good predictor of SDB at the different AHI cutoffs, where the area under ROC curve (AUC) ranged from 0.908 to 0.958. The cutoff based on maximal accuracy for ODI to predict AHI Ͼ5 (including all OSA), AHI Ͼ15 (including moderate and severe OSA) and AHI Ͼ30 (including severe OSA) was ODI Ͼ5, ODI Ͼ15, and ODI Ͼ30. The accuracy was 86% (CI: 83 to 88), 86% (CI: 83 to 89), and 94% (CI: 92 to 96), respectively. The ODI cutoff that ensured a high sensitivity and good specificity to detect moderate and severe OSA (AHI Ͼ15) was ODI Ͼ10. ODI Ͼ10 as a cutoff effectively separated the patients with high probability of moderate and severe OSA (Fig. 5) . The predictive performance of ODI at selected cutoffs in the validation dataset was summarized in Table 5 . The optimal cutoffs for CT90 to predict AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30 were CT90 Ͼ0.7, CT90 Ͼ1.7, and CT90 Ͼ3.5, respectively (data not presented). 
DISCUSSION
This prospective cohort study showed that ODI had a strong correlation with the parameters measuring sleep breathing disorders from PSG. Although ODI slightly underestimated AHI by 1.6 Ϯ 10, ODI had a very high accuracy to predict AHI at cutoffs of 5, 15, and 30 with the area under ROC of 0.908 to 0.958. ODI Ͼ5 was a good predictor for AHI Ͼ5 with an accuracy of 87%, ODI Ͼ15 for AHI Ͼ15 with an accuracy of 84%, and ODI Ͼ30 for AHI Ͼ30 with an accuracy of 93.7%. The cutoff of ODI Ͼ10 had a high sensitivity (93.3%) to detect moderate and severe OSA. CT90 was less accurate in detecting SDB.
Because of the lack of a convenient, inexpensive, and accurate tool, it has been a challenge to precisely identify surgical patients with SDB in preoperative clinics. The results from this study suggest that nocturnal ODI from a high-resolution pulse oximetry during sleep can be a very useful tool in assisting anesthesiologists to recognize patients with SDB, which may guide perioperative management. Because the sensitivity of ODI Ͼ5 to detect patients with AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30 was 96.3%, 99.4%, and 100.0%, respectively, we would be confident to exclude the possibility of moderate to severe OSA if a patient had ODI Յ5. On the other hand, the specificity for ODI Ͼ15 to detect AHI Ͼ5, AHI Ͼ15 m and AHI Ͼ30 was 98%, 92.5%, and 81.6%, respectively; and the specificity for ODI Ͼ30 to detect AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30 was 99.4%, 99.4%, and 97.2%, respectively. Therefore, we would be confident to consider a patient with ODI Ͼ15 as having moderate to severe SDB, and a patient with ODI Ͼ30 as having severe SDB. If one cutoff of ODI needs to be chosen, ODI Ͼ10 would be a good choice as it could detect almost all patients with moderate and severe SDB, while still retaining a reasonable specificity.
With ODI from a nocturnal oximeter, it is possible to stratify surgical patients and allocate resources for postoperative monitoring based on OSA-related risk. It could also help us identify patients who might benefit from continuous positive airway pressure treatment. Netzer et al. have suggested that patients with strong clinical suspicion for SDB and ODI Ͼ15 on oximetry should have autocontinuous positive airway pressure titration at home. 22 Although using nocturnal oximetry to detect patients with SDB is not a new idea, 12, 13, [23] [24] [25] there are methodological issues in previously published studies. Several studies used PSG on a different night to evaluate the predictive performance of the oximeter. 13, 24, 26 Because of the environmental difference between home and sleep laboratory, and night-to-night variability in the frequency of sleep apnea and hypopnea, 27, 28 PSG not performed on the same night as oximetry may not be able to accurately evaluate the role of nocturnal oximetry in the diagnosis of OSA. One study in elderly habitual snorers, 24 which also used a decrease in Spo 2 of Ͼ4% to define ODI, showed that the sensitivity and specificity for ODI Ͼ10 to predict AHI Ն15 were 63% and 95%, respectively. The sensitivity is lower than the results in our study (93.3%), but their specificity is higher than in our data (74.6%). The results were from a validation dataset generated from original dataset by re-sampling with bootstrapping. Except N, all data presented as value (lower-upper 95% confidence limit). LR ϭ negative likelihood ratio; NPV ϭ negative predictive value; positive LR ϭ positive likelihood ratio; ODI ϭ oxygen desaturation index; PPV ϭ positive predictive value; AHI ϭ apnea-hypopnea index.
Two previous studies used off-line analysis of pulse oximetry data from PSG as the oximetry data against the PSG data to evaluate the predictive performance of oximetry. 23, 29 Because sampling frequency of the oximeter on PSG is usually higher than that of a stand-alone oximeter, and the same pulse oximetry data were also used to define a hypopnea episode of AHI, caution should be exercised when interpreting the results from these studies. Furthermore, no study has been done in surgical patients to evaluate the predictive accuracy for SDB. In our study, PSG and the oximeter were recorded simultaneously at patients' homes, which is a more natural sleeping environment than that in a sleep laboratory.
The different parameters from an oximeter have been investigated to acquire a better predictor for AHI or OSA. The parameters include ␦ index (the average of the absolute differences of oxygen saturation between successive 12-s intervals), 12, 23 ODI at the desaturation threshold of 2%, 3%, and 4%, 23, 30, 31 and CT90. 31, 32 CT90 had been shown to have weaker correlation with AHI, 32 which is consistent with our results. Parameters from the more complicated analysis of oximetry recording, such as frequency domain indices, 31 central tendency measure, 33 and other parameters [33] [34] [35] were also under investigation. It appears that ␦ index demonstrated a higher predictive accuracy, but there was no significant difference from ODI. 23 We focused our study on the predictive performance of ODI for two reasons. First, ODI is the most commonly used measurement and can be easily generated with commercially available programs. Second, the definition of ODI is similar to the oxygen desaturation requirement for scoring a hypopnea episode we adopted. 16 Although high-resolution pulse oximetry is a convenient and inexpensive way to detect SDB, it has some limitations. Because it only measures the oxygen saturation change and does not monitor nasal flow and respiratory effort, it is not able to distinguish OSA from central sleep apnea.
There are also limitations to our study. One is that there was a self-selection of patients involved in the patient recruiting process. Although we approached all patients who met the criteria for inclusion and tried to recruit them for the study, the patients with SDB-related symptoms were more willing to give consent. This may account for the high prevalence of SDB in the study population. This may also affect the positive and negative predictive value of the ODI and CT90. However, the sensitivity and specificity should not be affected.
Another limitation is that we used results from a portable PSG device (Embletta X100) as the standard to evaluate the predictive performance of high-resolution oximetry. Portable monitors are being incorporated into the clinical evaluation of SDB. 36 Embletta X100 is a level 2 diagnostic device for SDB, which is unattended sleep study equipment with a minimum of 7 channels, including EEG, electrooculogram, chin electromyogram, electrocardiogram or heart rate, airflow, respiratory effort, and oxygen saturation. 14 When applied to the patient by a trained technician and scored by a certified PSG technologist, parameters measuring SDB and sleep architecture from Embletta X100 were comparable to in-laboratory, standard PSG. 15 The third limitation of the study is that the predictive performance was validated in a dataset generated from original dataset by resampling, which might overestimate the predictive performance.
In conclusion, ODI from nocturnal oximetry was strongly correlated with the parameters measuring sleep breathing disorders from PSG. ODI was a good predictor of AHI. Based on maximal accuracy, ODI Ͼ5, ODI Ͼ15, and ODI Ͼ30 were good predictors for AHI Ͼ5, AHI Ͼ15, and AHI Ͼ30, respectively. The ODI Ͼ10 demonstrated a high sensitivity (93%) and reasonable specificity (75%) to detect moderate and severe SDB. It effectively identified the patients with moderate and severe OSA. ODI from a high-resolution nocturnal oximeter is a sensitive and specific tool to preoperatively detect undiagnosed SDB in surgical patients.
